Glenn Mattes
Director and Chief Operating Officer
Business and Management
Advantagene
United States of America
Biography
Glenn Mattes has been working in the pharmaceutical industry for over 30 years. He has held senior global leadership positions at Rhone Poulenc Rorer, Centocor and Johnson & Johnson. At J&J, he was Global President of Tibotec Therapeutics where he lead J&J’s oncology and infectious disease franchises that included Procrit® and Doxil®. During his career, he has managed a number of product franchises that achieved market leadership and sales in excess of $1 Billion including Taxotere (RPR) and Remicade (Centocor). In the most recent 5 years, Glenn has become a serial entrepreneur working with public and private clinical and pre-clinical stage companies in CEO, Board member or executive chair positions. He has successfully raised funding for these companies while managing their growth and market opportunities.
Research Interest
His research in Business and Management
